Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2019 1
2020 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in Rheumatoid Arthritis Patients in Greece: Analysis of the Greek Cohort of SENSE study.
Sidiropoulos P, Bounas A, Galanopoulos N, Vosvotekas G, Koukli EM, Georgiou P, Marketos N, Antachopoulou T, Kyriakakis A, Koronaiou M. Sidiropoulos P, et al. Among authors: koukli em. Mediterr J Rheumatol. 2022 Mar 31;33(1):14-34. doi: 10.31138/mjr.33.1.14. eCollection 2022 Mar. Mediterr J Rheumatol. 2022. PMID: 35611113 Free PMC article.
Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Tektonidou MG, Katsifis G, Georgountzos A, Theodoridou A, Koukli EM, Kandili A, Giokic-Kakavouli G, Karatsourakis TD. Tektonidou MG, et al. Among authors: koukli em. Ther Adv Musculoskelet Dis. 2020 Sep 28;12:1759720X20949088. doi: 10.1177/1759720X20949088. eCollection 2020. Ther Adv Musculoskelet Dis. 2020. PMID: 33062067 Free PMC article.
Persistence and Adherence during the First Six Months of Tocilizumab Treatment Among Rheumatoid Arthritis Patients in Routine Clinical Practice in Greece. Results from the Single Arm REMISSION II Study (NCT01649817).
Markatseli TE, Theodoridou A, Zakalka M, Koukli E, Triantafyllidou E, Tsalavos S, Andrianakos A, Drosos AA. Markatseli TE, et al. Among authors: koukli e. Mediterr J Rheumatol. 2019 Sep 30;30(3):177-185. doi: 10.31138/mjr.30.3.177. eCollection 2019 Sep. Mediterr J Rheumatol. 2019. PMID: 32185362 Free PMC article.
Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
Karanikolas GN, Koukli EM, Katsalira A, Arida A, Petrou D, Komninou E, Fragiadaki K, Zacharioudaki A, Lasithiotakis I, Giavri E, Vaiopoulos G, Sfikakis PP. Karanikolas GN, et al. Among authors: koukli em. J Rheumatol. 2011 Nov;38(11):2466-74. doi: 10.3899/jrheum.110242. Epub 2011 Sep 1. J Rheumatol. 2011. PMID: 21885499 Clinical Trial.